An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4

被引:289
|
作者
Motshwene, Precious G.
Moncrieffe, Martin C.
Grossmann, J. Guenter [2 ]
Kao, Cheng [4 ]
Ayaluru, Murali [4 ]
Sandercock, Alan M. [3 ]
Robinson, Carol V. [3 ]
Latz, Eicke [5 ]
Gay, Nicholas J. [1 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England
[3] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[4] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA
[5] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01655 USA
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会; 新加坡国家研究基金会;
关键词
DEATH DOMAIN; STRUCTURAL BASIS; MASS-SPECTROMETRY; INNATE IMMUNITY; HIGH-RESOLUTION; TIR-DOMAIN; COMPLEX; PROTEIN; SCATTERING; REGULATOR;
D O I
10.1074/jbc.M109.022392
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) mediate responses to pathogen-associated molecules as part of the vertebrate innate immune response to infection. Receptor dimerization is coupled to downstream signal transduction by the recruitment of a post-receptor complex containing the adaptor protein MyD88 and the IRAK protein kinases. In this work, we show that the death domains of human MyD88 and IRAK-4 assemble into closed complexes having unusual stoichiometries of 7:4 and 8:4, the Myddosome. Formation of the Myddosome is likely to be a key event for TLR4 signaling in vivo as we show here that pathway activation requires that the receptors cluster into lipid rafts. Taken together, these findings indicate that TLR activation causes the formation of a highly oligomeric signaling platform analogous to the death-inducing signaling complex of the Fas receptor pathway.
引用
收藏
页码:25404 / 25411
页数:8
相关论文
共 50 条
  • [1] Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4
    Burns, K
    Janssens, S
    Brissoni, B
    Olivos, N
    Beyaert, R
    Tschopp, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02): : 263 - 268
  • [2] Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases
    Xiang, Wang
    Chao, Zhang-Yong
    Feng, Du-Yi
    REVIEWS IN THE NEUROSCIENCES, 2015, 26 (04) : 407 - 414
  • [3] Beyonc MyD88 and TRIF pathways in Toll-like receptor signaling
    Piras, Vincent
    Selvarajoo, Kumar
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [4] The role of oligomeric scaffolds in inflammatory signal transduction though Toll-like receptors and MyD88
    Gay, Nicholas J.
    Moncrieffe, Martin C.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2019, 48 : S61 - S61
  • [5] Mal (MyD88 Adapter-like) is required for Toll-like receptor-4 signal transduction
    Fitzgerald, KA
    Palsson-McDermott, EM
    Bowie, AG
    Jeffries, CA
    Mansell, A
    Brady, G
    Brint, B
    Dunne, A
    Gray, P
    Harte, MT
    McMurray, D
    Smith, DE
    Sims, JE
    Bird, TA
    O'Neill, LAJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 33 - 33
  • [6] Toll-Like Receptor 5 Modulates Myd88-Dependent Toll-Like Receptor 4 Signaling
    Johnson, C. G.
    Sciurba, J.
    Rice, A.
    Aloor, J.
    Cyphert, J.
    Bulek, K.
    Li, X.
    Fessler, M. B.
    Garantziotis, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Discovering differential activation machinery of the Toll-like receptor 4 signaling pathways in MyD88 knockouts
    Selvarajoo, K
    FEBS LETTERS, 2006, 580 (05): : 1457 - 1464
  • [8] Expression and signaling of Toll-like receptor 4 (TLR4) and MyD88 in ovarian carcinoma cells
    Szajnik, M. E.
    Szczepanski, M. J.
    Czystowska, M.
    Elishaev, E.
    Mandapathil, M.
    Nowak-Markwitz, E.
    Spaczynski, M.
    Whiteside, T. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
    Picard, Capucine
    von Bernuth, Horst
    Ghandil, Pegah
    Chrabieh, Maya
    Levy, Ofer
    Arkwright, Peter D.
    McDonald, Douglas
    Geha, Raif S.
    Takada, Hidetoshi
    Krause, Jens C.
    Creech, C. Buddy
    Ku, Cheng-Lung
    Ehl, Stephan
    Marodi, Laszlo
    Al-Muhsen, Saleh
    Al-Hajjar, Sami
    Al-Ghonaium, Abdulaziz
    Day-Good, Noorbibi K.
    Holland, Steven M.
    Gallin, John I.
    Chapel, Helen
    Speert, David P.
    Rodriguez-Gallego, Carlos
    Colino, Elena
    Garty, Ben-Zion
    Roifman, Chaim
    Hara, Toshiro
    Yoshikawa, Hideto
    Nonoyama, Shigeaki
    Domachowske, Joseph
    Issekutz, Andrew C.
    Tang, Mimi
    Smart, Joanne
    Zitnik, Simona Eva
    Hoarau, Cyrille
    Kumararatne, Dinakantha S.
    Thrasher, Adrian J.
    Davies, E. Graham
    Bethune, Claire
    Sirvent, Nicolas
    de Ricaud, Dominique
    Camcioglu, Yildiz
    Vasconcelos, Julia
    Guedes, Margarida
    Vitor, Artur Bonito
    Rodrigo, Carlos
    Almazan, Francisco
    Mendez, Maria
    Ignacio Arostegui, Juan
    Alsina, Laia
    MEDICINE, 2010, 89 (06) : 403 - 425
  • [10] Absence of TRAM restricts toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway
    Harari, Olivier A.
    Alcaide, Pilar
    Ahl, Daniela
    Luscinskas, F. William
    Liao, James K.
    CIRCULATION RESEARCH, 2006, 98 (09) : 1134 - 1140